Zhu J et al. |
Mevalonate-Farnesal Biosynthesis in Ticks: Comparative Synganglion Transcriptomics and a New Perspective. |
2016 |
PLoS ONE |
pmid:26959814
|
Torabi S and Mo H |
Trans, trans-farnesol as a mevalonate-derived inducer of murine 3T3-F442A pre-adipocyte differentiation. |
2016 |
Exp. Biol. Med. (Maywood) |
pmid:26660152
|
Inoue Y et al. |
Farnesol-Induced Disruption of the Staphylococcus aureus Cytoplasmic Membrane. |
2016 |
Biol. Pharm. Bull. |
pmid:27150138
|
Léger T et al. |
The Metacaspase (Mca1p) Restricts O-glycosylation During Farnesol-induced Apoptosis in Candida albicans. |
2016 |
Mol. Cell Proteomics |
pmid:27125826
|
Cheng HL et al. |
Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways. |
2016 |
Oncotarget |
pmid:26848867
|
Jung SI et al. |
Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades. |
2016 |
PLoS ONE |
pmid:26848577
|
Supuran CT |
Nanoparticles for controlled release of anti-biofilm agents WO2014130994 (A1): a patent evaluation. |
2015 |
Expert Opin Ther Pat |
pmid:26028186
|
Leonhardt I et al. |
The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity. |
2015 |
MBio |
pmid:25784697
|
Horev B et al. |
pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. |
2015 |
ACS Nano |
pmid:25661192
|
De Loof A |
The essence of female-male physiological dimorphism: differential Ca2+-homeostasis enabled by the interplay between farnesol-like endogenous sesquiterpenoids and sex-steroids? The Calcigender paradigm. |
2015 |
Gen. Comp. Endocrinol. |
pmid:25540913
|